Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance.


Journal

Drug safety
ISSN: 1179-1942
Titre abrégé: Drug Saf
Pays: New Zealand
ID NLM: 9002928

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 17 1 2019
medline: 30 1 2020
entrez: 17 1 2019
Statut: ppublish

Résumé

Integration of controlled vocabulary-based electronic health record (EHR) observational data is essential for real-time large-scale pharmacovigilance studies. To provide a semantically enriched adverse drug reaction (ADR) dictionary for post-market drug safety research and enable multicenter EHR-based extensive ADR signal detection and evaluation, we developed a comprehensive controlled vocabulary-based ADR signal dictionary (CVAD) for pharmacovigilance. A CVAD consists of (1) administrative disease classifications of the International Classification of Diseases (ICD) codes mapped to the Medical Dictionary for Regulatory Activities Preferred Terms (MedDRA Of the standard 4514 MedDRA CVAD had a high coverage of ADRs and integrated standard controlled vocabularies to the EHR data sources, and researchers can take advantage of these features for EHR observational data-based extensive pharmacovigilance studies to improve sensitivity and specificity.

Identifiants

pubmed: 30649749
doi: 10.1007/s40264-018-0767-7
pii: 10.1007/s40264-018-0767-7
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

657-670

Commentaires et corrections

Type : CommentIn

Références

Clin Pharmacol Ther. 2012 Mar;91(3):467-74
pubmed: 22237257
J Biomed Inform. 2014 Oct;51:191-9
pubmed: 24928448
J Am Med Inform Assoc. 2017 Jul 1;24(4):697-708
pubmed: 28087585
Nucleic Acids Res. 2015 Jan;43(Database issue):D907-13
pubmed: 25361966
Bioinformatics. 2015 Feb 15;31(4):612-3
pubmed: 25380960
Stud Health Technol Inform. 2006;122:989-90
pubmed: 17102503
Nat Rev Drug Discov. 2009 Oct;8(10):779-82
pubmed: 19763106
Stud Health Technol Inform. 2006;122:718-21
pubmed: 17102357
Antimicrob Agents Chemother. 2013 Feb;57(2):734-44
pubmed: 23165462
J Am Med Inform Assoc. 2013 Sep-Oct;20(5):947-53
pubmed: 23703825
Br J Clin Pharmacol. 2013 Sep;76 Suppl 1:69-77
pubmed: 23586589
Lancet. 2000 Oct 7;356(9237):1255-9
pubmed: 11072960
Clin Pharmacol Ther. 2013 Jun;93(6):547-55
pubmed: 23571773
Drug Saf. 2015 Mar;38(3):219-32
pubmed: 25749722
J Am Med Inform Assoc. 2013 May 1;20(3):420-6
pubmed: 23161894
Front Pharmacol. 2018 Aug 07;9:875
pubmed: 30131701
J Am Med Inform Assoc. 2014 May-Jun;21(3):547-57
pubmed: 24222671
BMC Health Serv Res. 2014 Mar 13;14:125
pubmed: 24620750
J Am Med Inform Assoc. 2010 Nov-Dec;17(6):652-62
pubmed: 20962127
Stat Med. 2012 Dec 30;31(30):4401-15
pubmed: 23015364
Comput Inform Nurs. 2013 Jan;31(1):45-51
pubmed: 23114393
BMJ. 2002 Oct 12;325(7368):828-31
pubmed: 12376447
Eur J Clin Pharmacol. 2008 Aug;64(8):743-52
pubmed: 18523760
J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60
pubmed: 22037893
Biol Pharm Bull. 2016;39(11):1846-1851
pubmed: 27803456
Methods Inf Med. 2015;54(1):24-31
pubmed: 25487120
Clin Pharmacol Ther. 2012 Jun;91(6):1010-21
pubmed: 22549283
Br J Clin Pharmacol. 2003 Dec;56(6):658-63
pubmed: 14616426
Drug Saf. 2015 Oct;38(10):895-908
pubmed: 26153397
Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):598-607
pubmed: 21472818
J Am Med Inform Assoc. 2014 Mar-Apr;21(2):308-14
pubmed: 23907285
Clin Pharmacol Ther. 2012 Aug;92(2):228-34
pubmed: 22713699
Stud Health Technol Inform. 2015;216:574-8
pubmed: 26262116
Expert Opin Drug Saf. 2005 Sep;4(5):929-48
pubmed: 16111454
Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):597-602
pubmed: 22337264
Drug Saf. 2017 Oct;40(10):855-869
pubmed: 28735357
Drugs Real World Outcomes. 2016 May 4;3(2):231-238
pubmed: 27398302
J Biomed Inform. 2012 Aug;45(4):689-96
pubmed: 22683994
IEEE Trans Inf Technol Biomed. 2011 May;15(3):428-37
pubmed: 21435986
J Biomed Inform. 2014 Dec;52:36-42
pubmed: 24177317
Mol Syst Biol. 2010;6:343
pubmed: 20087340
Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):647-50
pubmed: 12512239
Saudi Pharm J. 2015 Oct;23(5):515-22
pubmed: 26594117
J Biomed Semantics. 2012 Dec 20;3(1):15
pubmed: 23256479
J Thromb Thrombolysis. 2013 Apr;35(3):312-9
pubmed: 23479259
BMC Pharmacol Toxicol. 2013 Jan 08;14:5
pubmed: 23298396
Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11
pubmed: 21182150
Ther Drug Monit. 2013 Jun;35(3):360-6
pubmed: 23666575

Auteurs

Suehyun Lee (S)

Division of Biomedical Informatics, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Korea.
Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Korea.

Jongsoo Han (J)

Division of Biomedical Informatics, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Korea.

Rae Woong Park (RW)

Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.

Grace Juyun Kim (GJ)

Division of Biomedical Informatics, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Korea.

John Hoon Rim (JH)

Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Physician-Scientist Program, Department of Medicine, Yonsei University Graduate School of Medicine, Seoul, Korea.
Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.

Jooyoung Cho (J)

Physician-Scientist Program, Department of Medicine, Yonsei University Graduate School of Medicine, Seoul, Korea.
Department of Laboratory Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.

Kye Hwa Lee (KH)

Division of Biomedical Informatics, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Korea.
Precision Medicine Center, Seoul National University Hospital, Seoul, Korea.

Jisan Lee (J)

College of Nursing, Catholic University of Pusan, Busan, Korea.

Sujeong Kim (S)

College of Nursing, Seattle University, Seattle, USA.

Ju Han Kim (JH)

Division of Biomedical Informatics, Seoul National University Biomedical Informatics (SNUBI), Seoul National University College of Medicine, Seoul, Korea. juhan@snu.ac.kr.
Precision Medicine Center, Seoul National University Hospital, Seoul, Korea. juhan@snu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH